Erratum: The peroxisome proliferator-activated receptor-γ ligand 15-DeoxyΔ12,14prostaglandin J2reduces the organ injury in hemorrhagic shock (Shock (2004) 22:6 (555-561) DOI: 10.1097/01.shk.0000144132.13900.24);The peroxisome proliferator-activated receptor-γ ligand 15-deoxy Δ12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock

Shock

Volumn 22, Issue 6, 2004, Pages 555-561

  Abdelrahman, Maha ^a   Collin, Marika ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Ischemia reperfusion; PPAR ; Shock

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; DIMETHYL SULFOXIDE; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA BLOCKING AGENT; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG RECEPTOR BINDING; HEMORRHAGIC SHOCK; IN VIVO STUDY; INTESTINE INJURY; KIDNEY FAILURE; LIVER INJURY; LUNG INJURY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; RAT; RESUSCITATION;

EID: 9644275533     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000002341     Document Type: Erratum

References (26)

1. Straus DS, Glass CK: Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185-210, 2001.
2. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998.
3. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82, 1998.
4. 1: an effect associated with heat shock transcription factor activation. Proc Natl Acad Sci USA 94:746-750, 1997.
5. 2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. J Neuroimmunol 115:28-35, 2001.
6. Pasceri V, Wu HD, Willerson JT, Yeh ET: Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 101:235-238, 2000.
7. 2. Biochem Biophys Res Commun 283:750-755, 2001.
8. Colville-Nash PR, Qureshi SS, Willis D, Willoughby DA: Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161:978-984, 1998.
9. 2. J Immunol 166:7104-7111, 2001.
10. Santoro MG: Heat shock factors and the control of the stress response. Biochem Pharmacol 59:55-63, 2000.
11. Ianaro A, Ialenti A, Maffia P, Pisano B, Di Rosa M: HSF1/hsp72 pathway as an endogenous anti-inflammatory system. FEBS Lett 499:239-244, 2001.
12. Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H: 15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 106:189-197, 2000.
13. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C: Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16:1027-1040, 2002.
14. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, Thiemermann C: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 135:496-510, 2002.
15. 2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br J Pharmacol 138:678-688, 2003.
16. Leesnitzer LM, Parks DJ, Bledsoe RK, Cobb JE, Collins JL, Consler TG, Davis RG, Hull-Ryde EA, Lenhard JM, Patel L, Plunket KD, Shenk JL, Stimmel JB, Therapontos C, Willson TM, Blanchard SG: Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640-6650, 2002.
17. Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW: IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci USA 98:2443-2448, 2001.
18. Fu M, Zhang J, Lin YY, Zhu X, Willson TM, Chen YE: Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 294:597-601, 2002.
19. Abdelrahman M, Sharpies EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22:63-69, 2004.
20. 2 reduces the liver injury in endotoxic shock. Eur J Pharmacol 476:257-258, 2003.
21. Thiemermann C, Ruetten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851, 1995.
22. Baue AE: MOF/MODS, SIRS: an update. Shock 6(suppl 1):S1-S5, 1996.
23. Fry DE, Pearlstein L, Fulton RL, Polk HC Jr: Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115:136-140, 1980.
24. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79-89, 1998.
25. Guyton K, Zingarelli B, Ashton S, Teti G, Tempel G, Reilly C, Gilkeson G, Halushka P, Cook J: Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock 20:56-62, 2003.
26. Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH: In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 104:2588-2594, 2001.